VR Logo

Arcutis Biotherapeutics Inc. (ARQT) download report


Healthcare | Biotechnology & Pharma Research

Arcutis Biotherapeutics Inc. (ARQT) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

IPO Date: 31-Jan-2020

Pres, CEO & Director: Mr. Todd Franklin Watanabe M.A.

Co-Founder & Independent Director: Dr. Bhaskar Chaudhuri Ph.D.

Listing: NASDAQ: ARQT

Country: United States

Headquarters: Westlake Village, CA

Website: https://www.arcutis.com

Key Facts

Market cap: $1,137.37 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-234.64 Mln

Cash: $343.60 Mln

Total Debt: $77.86 Mln

Insider's Holding: 4.34%

Liquidity: Low

52 Week range: $13.59 - 27.45

Shares outstanding: 51,418,000

5 Years Aggregate:

  • CFO: $-348.36 Mln
  • EBITDA: $-409.38 Mln
  • Net Profit: $-408.26 Mln

Stock Performance

Time Period Arcutis Biotherapeutics (ARQT) S&P BSE Sensex S&P Small-Cap 600
YTD3.81-9.18-18.78
1 month2.57-4.78-8.00
3 months11.79-9.66-13.65
1 Year-21.110.81-17.19
3 Years--10.336.10
5 Years--11.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year Arcutis Biotherapeutics (ARQT) S&P Small-Cap 600 S&P BSE Sensex
2021-26.2725.2721.99